Clinical Trial Update: A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose [Phase 1]

View source ↗

Summary

A Phase 1 study completed to assess recovery, excretion, and pharmacokinetics of radiolabeled GSK1322322 after intravenous and oral dosing in bacterial infectio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• GSK1322322

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Bacterial | Phase 1 | Status: COMPLETED